The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
NSAIDs Drug-Global Market Insights and Sales Trends 2024
Synopsis
The global NSAIDs Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of NSAIDs Drug in various end use industries. The expanding demands from the Hospitals, Clinics and Drugstores,, are propelling NSAIDs Drug market. Ibuprofen, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Naproxen segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for NSAIDs Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global NSAIDs Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global NSAIDs Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, NSAIDs Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of NSAIDs Drug covered in this report include Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo and Merck, etc.
The global NSAIDs Drug market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue
Global NSAIDs Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global NSAIDs Drug market, Segment by Type:
Ibuprofen
Naproxen
Global NSAIDs Drug market, by Application
Hospitals
Clinics
Drugstores
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of NSAIDs Drug companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global NSAIDs Drug market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of NSAIDs Drug in various end use industries. The expanding demands from the Hospitals, Clinics and Drugstores,, are propelling NSAIDs Drug market. Ibuprofen, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Naproxen segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for NSAIDs Drug, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global NSAIDs Drug market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global NSAIDs Drug market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, NSAIDs Drug sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of NSAIDs Drug covered in this report include Pfizer, GSK, Grunenthal, Bayer, Sanofi, Eli Lilly, AstraZeneca, Endo and Merck, etc.
The global NSAIDs Drug market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
GSK
Grunenthal
Bayer
Sanofi
Eli Lilly
AstraZeneca
Endo
Merck
Depomed
Yunnan Baiyao
Teva
J&J
Allergan
Purdue
Global NSAIDs Drug market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global NSAIDs Drug market, Segment by Type:
Ibuprofen
Naproxen
Global NSAIDs Drug market, by Application
Hospitals
Clinics
Drugstores
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of NSAIDs Drug companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of NSAIDs Drug
1.1 NSAIDs Drug Market Overview
1.1.1 NSAIDs Drug Product Scope
1.1.2 NSAIDs Drug Market Status and Outlook
1.2 Global NSAIDs Drug Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global NSAIDs Drug Market Size by Region (2018-2029)
1.4 Global NSAIDs Drug Historic Market Size by Region (2018-2023)
1.5 Global NSAIDs Drug Market Size Forecast by Region (2024-2029)
1.6 Key Regions, NSAIDs Drug Market Size (2018-2029)
1.6.1 North America NSAIDs Drug Market Size (2018-2029)
1.6.2 Europe NSAIDs Drug Market Size (2018-2029)
1.6.3 Asia-Pacific NSAIDs Drug Market Size (2018-2029)
1.6.4 Latin America NSAIDs Drug Market Size (2018-2029)
1.6.5 Middle East & Africa NSAIDs Drug Market Size (2018-2029)
2 NSAIDs Drug Market by Type
2.1 Introduction
2.1.1 Ibuprofen
2.1.2 Naproxen
2.2 Global NSAIDs Drug Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global NSAIDs Drug Historic Market Size by Type (2018-2023)
2.2.2 Global NSAIDs Drug Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America NSAIDs Drug Revenue Breakdown by Type (2018-2029)
2.3.2 Europe NSAIDs Drug Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific NSAIDs Drug Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America NSAIDs Drug Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa NSAIDs Drug Revenue Breakdown by Type (2018-2029)
3 NSAIDs Drug Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Drugstores
3.2 Global NSAIDs Drug Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global NSAIDs Drug Historic Market Size by Application (2018-2023)
3.2.2 Global NSAIDs Drug Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America NSAIDs Drug Revenue Breakdown by Application (2018-2029)
3.3.2 Europe NSAIDs Drug Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific NSAIDs Drug Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America NSAIDs Drug Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa NSAIDs Drug Revenue Breakdown by Application (2018-2029)
4 NSAIDs Drug Competition Analysis by Players
4.1 Global NSAIDs Drug Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in NSAIDs Drug as of 2022)
4.3 Date of Key Players Enter into NSAIDs Drug Market
4.4 Global Top Players NSAIDs Drug Headquarters and Area Served
4.5 Key Players NSAIDs Drug Product Solution and Service
4.6 Competitive Status
4.6.1 NSAIDs Drug Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer NSAIDs Drug Products, Services and Solutions
5.1.4 Pfizer NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 GSK
5.2.1 GSK Profile
5.2.2 GSK Main Business
5.2.3 GSK NSAIDs Drug Products, Services and Solutions
5.2.4 GSK NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.2.5 GSK Recent Developments
5.3 Grunenthal
5.3.1 Grunenthal Profile
5.3.2 Grunenthal Main Business
5.3.3 Grunenthal NSAIDs Drug Products, Services and Solutions
5.3.4 Grunenthal NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.3.5 Bayer Recent Developments
5.4 Bayer
5.4.1 Bayer Profile
5.4.2 Bayer Main Business
5.4.3 Bayer NSAIDs Drug Products, Services and Solutions
5.4.4 Bayer NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.4.5 Bayer Recent Developments
5.5 Sanofi
5.5.1 Sanofi Profile
5.5.2 Sanofi Main Business
5.5.3 Sanofi NSAIDs Drug Products, Services and Solutions
5.5.4 Sanofi NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.5.5 Sanofi Recent Developments
5.6 Eli Lilly
5.6.1 Eli Lilly Profile
5.6.2 Eli Lilly Main Business
5.6.3 Eli Lilly NSAIDs Drug Products, Services and Solutions
5.6.4 Eli Lilly NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.6.5 Eli Lilly Recent Developments
5.7 AstraZeneca
5.7.1 AstraZeneca Profile
5.7.2 AstraZeneca Main Business
5.7.3 AstraZeneca NSAIDs Drug Products, Services and Solutions
5.7.4 AstraZeneca NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.7.5 AstraZeneca Recent Developments
5.8 Endo
5.8.1 Endo Profile
5.8.2 Endo Main Business
5.8.3 Endo NSAIDs Drug Products, Services and Solutions
5.8.4 Endo NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.8.5 Endo Recent Developments
5.9 Merck
5.9.1 Merck Profile
5.9.2 Merck Main Business
5.9.3 Merck NSAIDs Drug Products, Services and Solutions
5.9.4 Merck NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.9.5 Merck Recent Developments
5.10 Depomed
5.10.1 Depomed Profile
5.10.2 Depomed Main Business
5.10.3 Depomed NSAIDs Drug Products, Services and Solutions
5.10.4 Depomed NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.10.5 Depomed Recent Developments
5.11 Yunnan Baiyao
5.11.1 Yunnan Baiyao Profile
5.11.2 Yunnan Baiyao Main Business
5.11.3 Yunnan Baiyao NSAIDs Drug Products, Services and Solutions
5.11.4 Yunnan Baiyao NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.11.5 Yunnan Baiyao Recent Developments
5.12 Teva
5.12.1 Teva Profile
5.12.2 Teva Main Business
5.12.3 Teva NSAIDs Drug Products, Services and Solutions
5.12.4 Teva NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.12.5 Teva Recent Developments
5.13 J&J
5.13.1 J&J Profile
5.13.2 J&J Main Business
5.13.3 J&J NSAIDs Drug Products, Services and Solutions
5.13.4 J&J NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.13.5 J&J Recent Developments
5.14 Allergan
5.14.1 Allergan Profile
5.14.2 Allergan Main Business
5.14.3 Allergan NSAIDs Drug Products, Services and Solutions
5.14.4 Allergan NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.14.5 Allergan Recent Developments
5.15 Purdue
5.15.1 Purdue Profile
5.15.2 Purdue Main Business
5.15.3 Purdue NSAIDs Drug Products, Services and Solutions
5.15.4 Purdue NSAIDs Drug Revenue (US$ Million) & (2018-2023)
5.15.5 Purdue Recent Developments
6 North America
6.1 North America NSAIDs Drug Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe NSAIDs Drug Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific NSAIDs Drug Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America NSAIDs Drug Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa NSAIDs Drug Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 NSAIDs Drug Market Dynamics
11.1 NSAIDs Drug Industry Trends
11.2 NSAIDs Drug Market Drivers
11.3 NSAIDs Drug Market Challenges
11.4 NSAIDs Drug Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
